Petaquilla Minerals (PTQMF) 0.0010 $PTQMF Urban

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Petaquilla Minerals (PTQMF) 0.0010 $PTQMF

Urban Communications Inc. Announces Resignation of CFO and Appointment of New CFO
Marketwired - Thu Jun 11, 7:20AM CDT
Urban Communications Inc. ("Company" (TSX VENTURE: UBN), one of the country's first telecommunications companies to deliver Gigabit Internet service to the home, announces that Chris Convey has resigned as Chief Financial Officer to move back to his native U.K., and Julie van Baarsen has been appointed acting Chief Financial Officer effective May 31, 2015.
UBN.VN: 0.080 (unch)

CopperBank Announces Board of Director Changes Including the Addition of Tony Ricci and Grants Stock Options
ACCESSWIRE - Mon Jun 08, 10:01AM CDT
VANCOUVER, BC / ACCESSWIRE / June 8, 2015 / CopperBank Resources Corp. ("CopperBank" or the "Company," CNSX : CBK) is pleased to announce the addition of Tony Ricci to the Board of Directors.
PTQ.TO: ()

Petaquilla Files Formal Civil Complaint Against Global Hunter Securities LLC
Marketwired - Tue Apr 21, 10:23AM CDT
Petaquilla Minerals Ltd (OTCBB: PTQMF)(FRANKFURT: P7Z) ("Petaquilla" or the "Company" On April 20, 2015, Petaquilla Minerals LTD. Filed an action against Global Hunter Securities, LLC in the United States District Court for the Southern District of New York seeking in excess of one hundred million dollars in damages arising from Global Hunter Securities, LLC's alleged breach of a confidentiality agreement when Global Hunter Securities was involved in a $200M bond offering by Petaquilla in 2012. The company will continue to provide updates as warranted.

Petaquilla Minerals Ltd. Signs US$25M Facility
Marketwired - Fri Jan 16, 6:14PM CST
Petaquilla Minerals Ltd. ("Petaquilla" or the "Company" (TSX: PTQ)(OTCBB: PTQMF)(FRANKFURT: P7Z) announces further to its press release dated January 8, 2015 that on January 15, 2015 it signed an investment trust profit sharing facility at 60% Petaquilla Minerals and 40% Baseline Financial Group, SA. 10% of the profit will go towards the administration of the trust.
PTQ.TO: ()

Petaquilla Minerals Ltd. Provides Status Report
Marketwired - Thu Jan 08, 2:56PM CST
Petaquilla Minerals Ltd. ("Petaquilla" or the "Company" (TSX: PTQ)(OTCBB: PTQMF)(FRANKFURT: P7Z) On October 20, 2014, the Company announced the filing of the Company's audited annual financial statements, related management's discussion and analysis and accompanying certifications for the 13-months ended July 31, 2014 (collectively, the "Required Filings", would not be completed by the prescribed deadline of October 29, 2014, for the filing of such documents (the "Default Announcement".
PTQ.TO: ()

IIROC Trade Halt - Petaquilla Minerals Ltd.
Newsfile Corp - Wed Dec 31, 7:03AM CST
The following issues have been halted by IIROC:

Petaquilla Minerals Ltd. Issues Statement Regarding TSX Delisting Review and Provides Third Default Status Report
Marketwire Canada - Mon Dec 15, 4:12PM CST
Petaquilla Minerals Ltd. (TSXTQ)(OTCBBTQMF)(FRANKFURT7Z) ("Petaquilla" or the "Company" advises that as announced by the TSX on November 27, 2014, it has been placed under review with respect to eligibility for continued listing on the TSX and must demonstrate that it meets all TSX requirements on or before January 26, 2015, in order to maintain its listing.
PTQ.TO: ()

TSX Delisting Review - Petaquilla Minerals Ltd. (Symbol: PTQ)
CNW Group - Thu Nov 27, 7:30AM CST
DELISTING REVIEW Petaquilla Minerals Ltd. (the "Company" - TSX is reviewing the common shares (Symbol: PTQ) of the Company with respect to meeting the continued listing requirements. The Company has been granted 60 days in which to regain compliance with these requirements, pursuant to the Remedial Review Process.
X.TO: 60.56 (-0.42), PTQ.TO: ()

Petaquilla Minerals Ltd. Provides Financing Update and Second Default Status Report
Marketwired - Tue Nov 25, 5:08PM CST
Further to its news release of October 1, 2014, Petaquilla Minerals Ltd. (TSX: PTQ)(OTCBB: PTQMF)(FRANKFURT: P7Z) ("Petaquilla" or the "Company" announces that closing of the bridge loan expected last month has been delayed due to issues that arose during due diligence. As a result, the Company is pursuing alternative financing arrangements.
PTQ.TO: ()

Petaquilla Minerals Ltd. Provides Default Status Report
Marketwired - Thu Nov 13, 1:32PM CST
Petaquilla Minerals Ltd. ("Petaquilla" or the "Company" (TSX: PTQ)(OTCBB: PTQMF)(FRANKFURT: P7Z) provides this biweekly default status report in accordance with the alternative information guidelines in National Policy 12-203, Cease Trade Orders for Continuous Disclosure Defaults ("NP 12-203".
PTQ.TO: ()

Petaquilla Minerals Ltd. Announces Expected Late Filing of Audited Annual Financial Statements
Marketwired - Mon Oct 20, 5:41PM CDT
Petaquilla Minerals Ltd. (TSX: PTQ)(OTCBB: PTQMF)(FRANKFURT: P7Z) ("Petaquilla" or the "Company" announces that it does not expect to file its audited annual financial statements for the 13 months ended July 31, 2014, and its management's discussion and analysis relating thereto (collectively, the "Required Filings" before the prescribed deadline of October 29, 2014.
PTQ.TO: ()

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 262

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 135

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 718

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 314

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 187

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 255

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 63

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 129

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 287

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 62

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Kearney's 2025 Global Cities Report Insights

Updated Category News Views 654

Global Cities Adapt to New Challenges and Emergence Global cities hold steady at the top as new hubs surge forward Top cities reaffirm their dominance in the Global Cities Index, showcasing remarkable resilience amidst global changes and uncertainties. The Global Cities Outlook indicates a noticeable shift as traditional leaders face turbulence, while emerging Gulf and...

Continue Reading
Vacca Family Law Group Enhances Support for Peaceful Divorce

Updated Category News Views 255

Empowering Families Through Non-Adversarial Divorce Solutions Families navigating the challenging process of separation now have renewed access to considerate and non-confrontational divorce options. Vacca Family Law Group has recently welcomed Attorney and Mediator Wendy Reimer, who brings nearly two decades of experience in family law and a strong background in...

Continue Reading
Ingredion Delivers Impressive Q3 Results, Upgrades Outlook

Updated Category News Views 55

Ingredion's Strong Performance in the Third Quarter Ingredion Incorporated (NYSE: INGR) has reported remarkable results for the third quarter of 2024, showcasing a noteworthy surge in both operating income and earnings per share (EPS). The global leader in ingredient solutions for the food and beverage industry achieved a stunning 26% increase in reported operating income...

Continue Reading
Insight into Learning Technologies Group Plc's Disclosure Mechanism

Updated Category News Views 193

Understanding the Public Opening Position Disclosure Process In the complex world of financial securities, understanding the disclosure requirements can feel daunting. However, the process outlined by the Takeover Code, particularly Rule 8.3, provides a structured approach for individuals and entities holding significant interests in relevant securities. This rule is...

Continue Reading
Avidity Biosciences Set to Inspire with Latest Presentations

Updated Category News Views 191

Avidity Biosciences' Key Presentations at the MDA Conference Avidity Biosciences, Inc. (Nasdaq: RNA), a pioneer in RNA therapeutics, is poised to make a significant impact at the upcoming Clinical and Scientific Conference organized by the Muscular Dystrophy Association (MDA). The event will showcase the latest advancements in the field and highlight groundbreaking...

Continue Reading